The incretin effect in critically ill patients: a case-control study

Medicin og biovidenskab

• Incretins 100%
• Critical Illness 71%
• Case-Control Studies 61%
• Glucose Tolerance Test 30%
• Glucagon-Like Peptide 1 27%
• Gastric Inhibitory Polypeptide 26%
• Glucose 18%
• Type 2 Diabetes Mellitus 17%
• Intravenous Infusions 17%
• Insulin 16%
• Blood Glucose 14%
• Glucagon 12%
• Intravenous Administration 11%
• Hyperglycemia 10%
• Intensive Care Units 9%
• Cytokines 7%
• C-Peptide 6%
• Insulin Secretion 5%
• Serum 5%
• Insulin Resistance 4%
• Research Design 4%
• Interleukin-6 4%
• Body Mass Index 4%
• Tumor Necrosis Factor-alpha 4%
• Hormones 4%
• Students 4%
• Healthy Volunteers 3%
• Inflammation 3%